RxDoctor Payments Data

Nicholas Persich

Gastroenterology · Metairie, LANPI 1235245705

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,770 of the $14,558 with a category attached, or 74.0%. Redhill Biopharma Inc. accounts for 77.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $6,207 and has fallen 99.6% since, to $23 in 2024.

$14,558in general payments, 2019–2025

Across 265 payments — averaging $54.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Redhill Biopharma Inc.$11K
  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$724
  • Takeda Pharmaceuticals U.S.A., Inc.$405
  • Johnson & Johnson$364
  • Gilead$236
  • plus $579 from 10 others

What the payments were for

  • Speaking & faculty fees$10,77074%
  • Travel & lodging$1401%
  • Food & beverage$3,61625%
  • Education$320%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,558 in reported general payments places this provider in the 85th percentile of 254 gastroenterology providers in Louisiana.

See all gastroenterology providers in Louisiana

Other gastroenterology in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →